EIEIO you are either an insider trading on potential unexpected news such as the FDA hold or a complete imbecile. Many GERN longer term investors were caught in the FDA 85% gap down when it happened. We were all awaiting or the Phase ll / lll trails to be initiated in the summer of 2014 as was stated by Scarlet and pumped by Irish-trader before that ominous day in March. What if you were fully vested at that time....waiting till SP reached at least your entry was your only choice without booking a major loss. Coming in after the news like you, especially had you been alerted before hand would be a no brainer and as such you are oblivious to the loses incurred by many retail investors holding this POS. SP is still below that of prehold levels??? Answer me Why that is if you are so "bright"
Hear your call drummer but as it is very distant management refuses to hear & respond. It appears that the deal with Jansen with many unknowns, yet to be ironed out was deliberately left that way in order for Jansen to act in response before SP got away from them if data results prove good. The trial was all turned over to them and therefore they are in control of releasing info. Who really knows if they'll even start infusing at some foreign sites only to pre-examine IMET's trial performance bfr. releasing data. They are not responsible to GERN's shareholders and Chippy by comments such as "if ever" appears to be playing into this game.
The timing of the highly questionable FDA hold makes the sound track of suspicious toads croaking in our pond even louder. I suspect Chippy was already engaged in talks when the hold went down. His Jan 2014 CC in San Fran with comments about the mechanisms at work wrt IMET "are still a mystery" almost forewarned of such a possible event. It certainly would have bought them both time to nail out a deal and delay trials by a year. Janssen with all their clout doesn't seem to be in an hurry to start the trials and this quiet time plays into the hands of the hedge funds that underwrote the secondary last year. They made their money back by the fist hold shorting this stock at the expense of retail investors gamed in this Congo longo bongo. Can totally relate to ur frustration....long from March 01 2014
AST up 4%
OHRP up 4.5%
KERX up 5%
POZN up 8.7%
ANTH up 11%
GERN needs viagra
MDBX isn't more than a pot play but it went up a relaxing 85% today. A great trade, not a good LT investment
what'd yah mean bojiggly? Gern is on a tear.....must be all those shorts being fed into the proverbial bon fire the church lady set. Oy vey of little faith.
stop ur BS JK Today's short numbers are 27million up by several 100K not 1 million. Virtually no change in overall numbers...without news I highly doubt we see any proverbial squeeze. The correction excuse is over for now so GERN must perform on it's own merit. The SP proves it and you've been wrong since July 1
considering all the shares I've been buying as I've been averaging down here in GERN I should be close becoming a trillionaire by the time GERN sells out yet I was content to only be a billionaire beaver.
All church of GERONTOLOGY members please join in prayer as we ask our spiritual leader the Church Lady to lead us away from sin and despair and avert that death cross that Satan is trying to aim for with our SP next week. Please take us up with some heavenly news. Amen from critter cam. Look towards the light.
we've been doing that in GERN for years. Sounds rather dull if you ask me.
just getting tired/bored of all the mindless pumping & or bashing with deliberate misleading intent by characters devoid of such. Hairy Potter entitles his thread "This is why GERN is falling" and then proceeds to pick through pointers in a recent publication omitting salient comments by the researchers such as, “I think in reality it is unlikely that you could reverse tumours by reversing just one mechanism, but it’s a very interesting finding,” concluded Dr. Chris Bakal from the Institute for Cancer Research in London."
IMET is in an advanced clinical phase ll/lll study possibly being granted BTS early as trial results substantiate earlier findings using a totally different mechanism whilst the article sited new science on another that is still in a lab research phase. Big difference.
maybe he'll buy some art work for Menlo Park. Investing in art can reap huge returns. Paul Gauguin's 'when will you marry?' went for $300 mil at auction this spring.
Imetelsat acts as a competitive enzyme inhibitor that binds and blocks the active site of the enzyme (a "telomerase template antagonist"), a mechanism of action which differs from that for the antisense oligonucleotide-mediated inhibition of telomerase activity through telomerase mRNA binding. Inhibition of telomerase activity in tumor cells by imetelstat results in telomere shortening, which leads to cell cycle arrest or apoptosis. I other words same results in arresting and killing cancer cells as injecting micro RNA in aggressive tumors. As the article stated this new Mayo research discovery is still a long ways off to clinical applications and that this new discovery will not be the silver bullet to cure cancer but goes a ways into a better understanding of the disease. and potential treatments. IMET is in phase ll trials and has shown unprecedented efficacy in treating MF and possibly other bone marrow cancers. IMET will rise like a phoenix, facial hair and all.
When is the question 2016? 2017? 2018?
Joko u r delusional. Not one of your pumps has reflected in a positive SP move. In fact the more you pump the lower we go. Markets have rebounded today and here we sit at barely holding $3.00. PATHETIC!